August 1, 2004European Journal of Heart Failure
Clinical Trials Update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and Meta-Analysis of Cardiac Resynchronisation Therapy
Population
Patients with heart failure and patients with end-stage renal disease (summary of multiple trials)
Comparison
Various interventions including carvedilol… vs Various comparators including placebo and…
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
2004 trial summaries provide historical context; leaves open relevance to contemporary HF management.
Structured PICO
P
Population
Patients with heart failure and patients with end-stage renal disease (summary of multiple trials)
I
Intervention
Various interventions including carvedilol, metoprolol, fosinopril, cardiac resynchronisation therapy, and general practitioner education
C
Comparator
Various comparators including placebo and alternative beta-blockers
O
Outcome
Various outcomes including mortality, cardiovascular events, left ventricular ejection fraction, and cognitive impairment
This review summarizes key clinical trial updates in heart failure management presented at the 2004 ESC Heart Failure meeting.
Cite This Study
Coletta et al. (2004) studied this question.